HUE037482T2 - Inos-inhibitorok alkalmazása vírushozam növelésére tenyészetben - Google Patents
Inos-inhibitorok alkalmazása vírushozam növelésére tenyészetbenInfo
- Publication number
- HUE037482T2 HUE037482T2 HUE14703459A HUE14703459A HUE037482T2 HU E037482 T2 HUE037482 T2 HU E037482T2 HU E14703459 A HUE14703459 A HU E14703459A HU E14703459 A HUE14703459 A HU E14703459A HU E037482 T2 HUE037482 T2 HU E037482T2
- Authority
- HU
- Hungary
- Prior art keywords
- culture
- virus yield
- inos inhibitors
- increase virus
- increase
- Prior art date
Links
- 101100396994 Drosophila melanogaster Inos gene Proteins 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16641—Use of virus, viral particle or viral elements as a vector
- C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16651—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361750175P | 2013-01-08 | 2013-01-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE037482T2 true HUE037482T2 (hu) | 2018-08-28 |
Family
ID=51167323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE14703459A HUE037482T2 (hu) | 2013-01-08 | 2014-01-07 | Inos-inhibitorok alkalmazása vírushozam növelésére tenyészetben |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US11299715B2 (https=) |
| EP (3) | EP2943567B1 (https=) |
| JP (2) | JP6534933B2 (https=) |
| KR (1) | KR102307279B1 (https=) |
| CN (1) | CN105008523B (https=) |
| AR (1) | AR094389A1 (https=) |
| AU (1) | AU2014205604B2 (https=) |
| BR (2) | BR112015016328B1 (https=) |
| CA (1) | CA2897444A1 (https=) |
| DK (1) | DK2943567T3 (https=) |
| ES (1) | ES2651763T3 (https=) |
| HK (1) | HK1249544A1 (https=) |
| HU (1) | HUE037482T2 (https=) |
| IL (1) | IL239824B (https=) |
| MX (2) | MX360470B (https=) |
| NO (1) | NO3050055T3 (https=) |
| RU (1) | RU2676733C2 (https=) |
| SG (3) | SG10201806715TA (https=) |
| TW (1) | TWI608102B (https=) |
| WO (1) | WO2014110053A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201703148TA (en) | 2014-11-05 | 2017-05-30 | Voyager Therapeutics Inc | Aadc polynucleotides for the treatment of parkinson's disease |
| CN119876138A (zh) | 2014-11-14 | 2025-04-25 | 沃雅戈治疗公司 | 调节性多核苷酸 |
| CA3193811A1 (en) | 2014-11-14 | 2016-05-19 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
| HK1245326A1 (zh) | 2014-12-12 | 2018-08-24 | Voyager Therapeutics, Inc. | 用於生产scaav的组合物和方法 |
| PL3436593T3 (pl) | 2016-03-28 | 2023-03-27 | Ultragenyx Pharmaceutical Inc. | Sposoby inaktywacji termicznej adenowirusów |
| CA3024448C (en) | 2016-05-18 | 2025-09-09 | Voyager Therapeutics, Inc. | MODULATING POLYNUCLEOTIDES |
| ES3012649T3 (en) | 2016-10-14 | 2025-04-09 | Ultragenyx Pharmaceutical Inc | Use of tonicifying agents to enhance recombinant adeno-associated virus yield |
| JP7142643B2 (ja) | 2017-03-22 | 2022-09-27 | ウルトラジェニックス ファーマシューティカル インコーポレイテッド | Ｈｄａｃ阻害剤またはｒｅｐタンパク質を伴う細胞培養方法 |
| JP7218303B2 (ja) | 2017-05-09 | 2023-02-06 | ウルトラジェニックス ファーマシューティカル インコーポレイテッド | トランスフェクション試薬を生成するための拡大可能な方法 |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| SG11202011296VA (en) | 2018-05-15 | 2020-12-30 | Voyager Therapeutics Inc | Compositions and methods for the treatment of parkinson's disease |
| CN110835622B (zh) * | 2018-08-16 | 2021-04-27 | 上海药明生物技术有限公司 | 用于调节哺乳动物细胞乳酸代谢的培养基及其应用 |
| US12281321B2 (en) | 2018-09-28 | 2025-04-22 | Voyager Therapeutics, Inc. | Frataxin expression constructs having engineered promoters and methods of use thereof |
| BR112022018658A2 (pt) | 2020-03-16 | 2022-12-20 | Ultragenyx Pharmaceutical Inc | Métodos para potencializar o rendimento de vírus adenoassociado recombinante |
| WO2023157976A1 (ja) * | 2022-02-21 | 2023-08-24 | 学校法人日本医科大学 | ウイルスベクター生産性増強剤及びウイルスベクターの製造方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| WO1992001070A1 (en) | 1990-07-09 | 1992-01-23 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | High efficiency packaging of mutant adeno-associated virus using amber suppressions |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| RU2012335C1 (ru) * | 1991-07-04 | 1994-05-15 | Уфимский научно-исследовательский институт глазных болезней | Ингибитор вируса простого герпеса |
| JP3534749B2 (ja) | 1991-08-20 | 2004-06-07 | アメリカ合衆国 | アデノウイルスが介在する胃腸管への遺伝子の輸送 |
| JP4044131B2 (ja) * | 1992-07-31 | 2008-02-06 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ヘルペスウイルスワクチン |
| US7223411B1 (en) | 1992-07-31 | 2007-05-29 | Dana-Farber Cancer Institute | Herpesvirus replication defective mutants |
| US6833271B2 (en) | 1996-12-04 | 2004-12-21 | Medi-Cult A/S | Serum-free cell culture media |
| GB9816856D0 (en) * | 1998-08-03 | 1998-09-30 | Univ London | Cell lines for virus growth |
| US6783972B1 (en) * | 1998-09-22 | 2004-08-31 | University Of Florida Research Foundation | Methods for large-scale production of recombinant AAV vectors |
| US6593123B1 (en) | 2000-08-07 | 2003-07-15 | Avigen, Inc. | Large-scale recombinant adeno-associated virus (rAAV) production and purification |
| US7091029B2 (en) * | 2002-09-23 | 2006-08-15 | Applied Genetics Technologies Corporation | High titer recombinant AAV production |
| US7427396B2 (en) | 2004-06-03 | 2008-09-23 | Genzyme Corporation | AAV vectors for gene delivery to the lung |
| CN100348718C (zh) * | 2005-10-18 | 2007-11-14 | 中国人民解放军军事医学科学院生物工程研究所 | 一种支持hek293细胞贴附培养的无动物来源成分无血清培养基 |
| CN101784532B (zh) * | 2007-06-29 | 2014-10-22 | 韩国化学研究院 | Hiv逆转录酶抑制剂 |
-
2014
- 2014-01-07 CA CA2897444A patent/CA2897444A1/en not_active Abandoned
- 2014-01-07 EP EP14703459.9A patent/EP2943567B1/en active Active
- 2014-01-07 SG SG10201806715TA patent/SG10201806715TA/en unknown
- 2014-01-07 JP JP2015551846A patent/JP6534933B2/ja active Active
- 2014-01-07 MX MX2015008861A patent/MX360470B/es active IP Right Grant
- 2014-01-07 RU RU2015133205A patent/RU2676733C2/ru active
- 2014-01-07 WO PCT/US2014/010553 patent/WO2014110053A1/en not_active Ceased
- 2014-01-07 BR BR112015016328-9A patent/BR112015016328B1/pt active IP Right Grant
- 2014-01-07 US US14/758,785 patent/US11299715B2/en active Active
- 2014-01-07 CN CN201480012376.2A patent/CN105008523B/zh active Active
- 2014-01-07 AU AU2014205604A patent/AU2014205604B2/en not_active Ceased
- 2014-01-07 HU HUE14703459A patent/HUE037482T2/hu unknown
- 2014-01-07 ES ES14703459.9T patent/ES2651763T3/es active Active
- 2014-01-07 SG SG10201913130PA patent/SG10201913130PA/en unknown
- 2014-01-07 EP EP19160865.2A patent/EP3521420A1/en not_active Withdrawn
- 2014-01-07 MX MX2018013366A patent/MX378877B/es unknown
- 2014-01-07 BR BR122020002822-0A patent/BR122020002822B1/pt active IP Right Grant
- 2014-01-07 DK DK14703459.9T patent/DK2943567T3/en active
- 2014-01-07 KR KR1020157021175A patent/KR102307279B1/ko active Active
- 2014-01-07 EP EP17184746.0A patent/EP3266866B1/en active Active
- 2014-01-07 TW TW103100466A patent/TWI608102B/zh active
- 2014-01-07 SG SG11201505333PA patent/SG11201505333PA/en unknown
- 2014-01-08 AR ARP140100065A patent/AR094389A1/es unknown
- 2014-09-26 NO NO14781027A patent/NO3050055T3/no unknown
-
2015
- 2015-07-07 IL IL239824A patent/IL239824B/en active IP Right Grant
-
2018
- 2018-07-10 HK HK18108963.6A patent/HK1249544A1/en unknown
-
2019
- 2019-05-28 JP JP2019098958A patent/JP6837094B2/ja active Active
-
2022
- 2022-03-03 US US17/686,245 patent/US20220340883A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE037482T2 (hu) | Inos-inhibitorok alkalmazása vírushozam növelésére tenyészetben | |
| IL285780A (en) | Tmprss6 irna compositions and methods of use thereof | |
| IL276761B1 (en) | Methods of inducing anesthesia | |
| IL252446A0 (en) | Inhibitors of hepatitis c virus | |
| SI2760831T1 (sl) | Inhibitorji replikacije virusov | |
| IL228538A0 (en) | Methods for increasing efficacy of folr1 cancer therapy | |
| LT2885010T (lt) | Tautopatijos gydymo būdai | |
| LT2914291T (lt) | Antikūnai prieš komplemento c1s ir jų panaudojimo būdai | |
| IL242394B (en) | Cenicriviroc compositions and methods of making and using the same | |
| LT2981255T (lt) | Empagliflozino terapiniai panaudojimo būdai | |
| HRP20170840T1 (hr) | Supstituirani ksantini i metode njihove uporabe | |
| HRP20190101T1 (hr) | Terapeutske uporabe empagliflozina | |
| DK2500036T3 (da) | MET-hæmmere til øgning af virkningen af radioterapi | |
| PL2928905T3 (pl) | Sposób oczyszczania białek terapeutycznych | |
| CO6821947A2 (es) | Inhibidores del virus de la hepatitis c | |
| CO6940424A2 (es) | Inhibidores del virus de la hepatitis c | |
| HUE045668T2 (hu) | Oldat készítmények módosított anti-IL-23p19 antitestekbõl | |
| HRP20181506T1 (hr) | Derivati heteroaril-butanske kiseline kao inhibitori lta4h | |
| SI2833884T1 (sl) | Uporaba CCR3-inhibitorjev | |
| CO6821952A2 (es) | Inihibidores del virus de la hepatitis c | |
| EP2968889A4 (en) | METHOD FOR DISTRIBUTING NANOHOUTS IN EXTINGUITS | |
| FR2994974B1 (fr) | Distillation reactive des dso | |
| IL287727A (en) | Use of phenoxypropylamine compounds to treat depression | |
| IL235909A0 (en) | Heteroaryl compounds and methods of use thereof | |
| LT3063287T (lt) | Monensino naudojimas rekombinantinių baltymų glikozilinimui reguliuoti |